PARP Inhibition Induces Synthetic Lethality and Adaptive Immunity in LKB1-Mutant Lung Cancer

Li-Li Long, Si-Cong Ma, Ze-Qin Guo, +15

Cancer Research

Interstitial pneumonitis associated with combined regimen of immunotherapy and conventional therapies—pharmacovigilance database analysis with real-world data validation

Xue‐Jun Guo, Xiao-Ting Cai, Zi-Xuan Rong, +13

BMC Medicine

Organ-specific metastatic landscape dissects PD-(L)1 blockade efficacy in advanced non-small cell lung cancer: applicability from clinical trials to real-world practice

Si-Cong Ma, Xue Bai, Xue‐Jun Guo, +15

BMC Medicine

PAI-1-driven SFRP2high cancer-associated fibroblasts hijack the abscopal effect of radioimmunotherapy

Yan-Pei Zhang, Ze-Qin Guo, Xiao-Ting Cai, +26

Cancer Cell

Effects of preventive therapy for latent tuberculosis infection and factors associated with treatment abandonment: a cross-sectional study

Huaping Huang, Guosheng Yuan, Yuhua Du, +7

Journal of Thoracic Disease

Assessment of anti-PD-(L)1 for patients with coexisting malignant tumor and tuberculosis classified by active, latent, and obsolete stage

Shan Su, Mei-Feng Ye, Xiao-Ting Cai, +12

BMC Medicine

Comprehensive assessment of base excision repair (BER)-related lncRNAs as prognostic and functional biomarkers in lung adenocarcinoma: implications for personalized therapeutics and immunomodulation

Junzheng Zhang, Lu Song, Guanrong Li, +5

Journal of Cancer Research and Clinical Oncology

CT-based radiomics nomogram for predicting visceral pleural invasion in peripheral T1-sized solid lung adenocarcinoma.

Xiao-Ting Cai, Ping Wang, Huihui Zhou, +4

PubMed